Vitamin C to Reduce Morning Cardiovascular Risk

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This study will test the efficacy of Vitamin C to counteract morning cardiovascular (CV) risk markers in a randomized, double blind, placebo controlled crossover pilot study. The participants will also perform morning typical behaviors such as arousal from sleep, change in posture (getting out of bed) and mild intensity physical activity; identical to the stressors encountered in everyday life. Primary dependent variables are markers of cardiovascular risk including vascular endothelial function and oxidative stress.
Epistemonikos ID: f581086bd56511ffe7bcb893874558e814df50e3
First added on: May 21, 2024